Related Experiment Video
Updated: Sep 23, 2025

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
Venous thromboembolism in COVID-19 patients and prediction model: a multicenter cohort study
Yi Lee1, Qasim Jehangir2, Pin Li3
1Department of Medicine, St. Joseph Mercy Oakland Hospital, 44405 Woodward Avenue, Pontiac, MI, 48341, USA. olive.csmu@gmail.com.
Insights
COVID-19 patients face a high risk of venous thromboembolism (VTE), leading to longer hospital stays. A random forest model identified key predictors for VTE, aiding clinical decisions on anticoagulation.
Area of Science:
- Medical research
- Clinical informatics
- Public health
Background:
- COVID-19 infection is associated with an elevated risk of venous thrombosis.
- Current anticoagulation strategies require further refinement through individualized risk assessment.
- Identifying specific risk factors for venous thromboembolism (VTE) in COVID-19 patients is crucial for improved management.
Purpose of the Study:
- To identify risk factors for VTE in hospitalized COVID-19 patients.
- To develop a predictive model for VTE risk stratification.
- To assist clinicians in VTE prevention and management decisions.
Main Methods:
- A retrospective analysis of adult COVID-19 patients from four health systems in Southeast Michigan (March-December 2020).
- Development and testing of four predictive models (random forest, logistic regression, multilinear regression, decision trees) for in-hospital VTE (deep vein thrombosis and pulmonary embolism).
- Evaluation of model performance using ROC curve and confusion matrix; comparison of hospital and ICU length of stay between VTE and non-VTE groups.
Main Results:
- 6.68% of 3531 COVID-19 admissions developed acute VTE.
- Patients with VTE experienced significantly longer hospital (12.2 vs. 8.8 days) and ICU (3.8 vs. 1.9 days) stays.
- The random forest model demonstrated superior performance, identifying blood pressure, electrolytes, renal function, hepatic enzymes, and inflammatory markers as key VTE predictors.
Conclusions:
- COVID-19 patients exhibit a substantial risk of VTE, associated with prolonged hospitalization.
- A random forest model effectively predicts VTE in COVID-19 patients.
- The identified predictors can guide physicians in clinical judgment regarding anticoagulation therapy.
Background:
Patients with COVID-19 infection are commonly reported to have an increased risk of venous thrombosis. The choice of anti-thrombotic agents and doses are currently being studied in randomized controlled trials and retrospective studies. There exists a need for individualized risk stratification of venous thromboembolism (VTE) to assist clinicians in decision-making on anticoagulation. We sought to identify the risk factors of VTE in COVID-19 patients, which could help physicians in the prevention, early identification, and management of VTE in hospitalized COVID-19 patients and improve clinical outcomes in these patients.
Method:
This is a multicenter, retrospective database of four main health systems in Southeast Michigan, United States. We compiled comprehensive data for adult COVID-19 patients who were admitted between 1st March 2020 and 31st December 2020. Four models, including the random forest, multiple logistic regression, multilinear regression, and decision trees, were built on the primary outcome of in-hospital acute deep vein thrombosis (DVT) and pulmonary embolism (PE) and tested for performance. The study also reported hospital length of stay (LOS) and intensive care unit (ICU) LOS in the VTE and the non-VTE patients. Four models were assessed using the area under the receiver operating characteristic curve and confusion matrix.
Results:
The cohort included 3531 admissions, 3526 had discharge diagnoses, and 6.68% of patients developed acute VTE (N = 236). VTE group had a longer hospital and ICU LOS than the non-VTE group (hospital LOS 12.2 days vs. 8.8 days, p < 0.001; ICU LOS 3.8 days vs. 1.9 days, p < 0.001). 9.8% of patients in the VTE group required more advanced oxygen support, compared to 2.7% of patients in the non-VTE group (p < 0.001). Among all four models, the random forest model had the best performance. The model suggested that blood pressure, electrolytes, renal function, hepatic enzymes, and inflammatory markers were predictors for in-hospital VTE in COVID-19 patients.
Conclusions:
Patients with COVID-19 have a high risk for VTE, and patients who developed VTE had a prolonged hospital and ICU stay. This random forest prediction model for VTE in COVID-19 patients identifies predictors which could aid physicians in making a clinical judgment on empirical dosages of anticoagulation.
More Related Videos
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis I: Introduction
Pulmonary Embolism I: Introduction
Venous Thrombosis IV: Nursing Management

